These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 28288074

  • 1. Racial Differences and Disparities in Osteoporosis-related Bone Health: Results From the PAADRN Randomized Controlled Trial.
    Cram P, Saag KG, Lou Y, Edmonds SW, Hall SF, Roblin DW, Wright NC, Jones MP, Wolinsky FD, PAADRN Investigators*.
    Med Care; 2017 Jun; 55(6):561-568. PubMed ID: 28288074
    [Abstract] [Full Text] [Related]

  • 2. Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial.
    Cram P, Wolinsky FD, Lou Y, Edmonds SW, Hall SF, Roblin DW, Wright NC, Jones MP, Saag KG, PAADRN Investigators.
    Osteoporos Int; 2016 Dec; 27(12):3513-3524. PubMed ID: 27363400
    [Abstract] [Full Text] [Related]

  • 3. The effects of a patient activation intervention on smoking and excessive drinking cessations: results from the PAADRN randomized controlled trial.
    Wolinsky FD, Lou Y, Edmonds SW, Saag KG, Roblin DW, Wright NC, Jones MP, Cram P, PAADRN Investigators.
    Osteoporos Int; 2017 Oct; 28(10):3055-3060. PubMed ID: 28573377
    [Abstract] [Full Text] [Related]

  • 4. The cost of a patient activation intervention for achieving successful outcomes: results from the PAADRN randomized controlled trial.
    Wolinsky FD, Hall SF, Lou Y, Edmonds SW, Saag KG, Roblin DW, Wright NC, Jones MP, Cram P, PAADRN Investigators, Curtis JR, Morgan SL, Schlechte JA, Williams JH, Zelman DJ.
    Osteoporos Int; 2017 Oct; 28(10):3061-3066. PubMed ID: 28620779
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The prevalence of overtreatment of osteoporosis: results from the PAADRN trial.
    Hall SF, Wright NC, Wolinsky FD, Lou Y, Edmonds S, Roblin D, Jones M, Saag K, Cram P.
    Arch Osteoporos; 2018 Sep 28; 13(1):103. PubMed ID: 30267162
    [Abstract] [Full Text] [Related]

  • 8. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat.
    Ont Health Technol Assess Ser; 2006 Sep 28; 6(20):1-180. PubMed ID: 23074491
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sex differences in osteoporosis self-efficacy among community-residing older adults presenting for DXA.
    Solimeo SL, Nguyen VT, Edmonds SW, Lou Y, Roblin DW, Saag KG, Cram P, Wolinsky FD.
    Osteoporos Int; 2019 May 28; 30(5):1033-1041. PubMed ID: 30701343
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 14. Disparities in osteoporosis screening between at-risk African-American and white women.
    Miller RG, Ashar BH, Cohen J, Camp M, Coombs C, Johnson E, Schneyer CR.
    J Gen Intern Med; 2005 Sep 01; 20(9):847-51. PubMed ID: 16117754
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Racial disparity in treatment of osteoporosis after diagnosis.
    Hamrick I, Whetstone LM, Cummings DM.
    Osteoporos Int; 2006 Sep 01; 17(11):1653-8. PubMed ID: 16871433
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of Values Affirmation on Reducing Racial Differences in Adherence to Hypertension Medication: The HYVALUE Randomized Clinical Trial.
    Daugherty SL, Helmkamp L, Vupputuri S, Hanratty R, Steiner JF, Blair IV, Dickinson LM, Maertens JA, Havranek EP.
    JAMA Netw Open; 2021 Dec 01; 4(12):e2139533. PubMed ID: 34913976
    [Abstract] [Full Text] [Related]

  • 20. Health care disparities in postmenopausal women referred for DXA screening.
    Hamrick I, Steinweg KK, Cummings DM, Whetstone LM.
    Fam Med; 2006 Apr 01; 38(4):265-9. PubMed ID: 16586173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.